Real-world management and patient perspectives on QOL with neuroendocrine tumours: An ANZ perspective

On 2 September 2020 a webinar was held titled “NET 2020” for Health Professionals and was sponsored by Novartis.

There were around 120 attendees at the event from across Australia which had a panel of NET Specialists providing information about current treatment options, an opportunity to take part in an in-depth discussion of a functional GEPNET patient case, a debate on the optimal clinical approach for non-functional GEPNET, and new data on quality of life issues affecting NET patients to improve supportive care. This article provides a summary of the presentations at the event which will be extremely interesting to the medical community.

Click the button below for full article.


Download here

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Racing for a Cure 2026 – thank you Rob!

NECA Joins Cancer Australia’s Low Survival Cancers Mission Roundtable

NECA CEO Meredith Cummins named Health and Social Services Government Relations Practitioner of the Year

The Faces of HTA Reform booklet is here

Neuroendocrine Cancer Day

Neuroendocrine Cancer Day is on 10 November, and every bit of support counts.

Create an event, share your artwork, or donate on our ‘Double Your Impact’ days. There are so many ways to stand with the NET community.